FONAR Corporation
FONAR Corporation (FONR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fonr · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for FONAR Corporation (FONR) measures how much investors pay for each dollar of the company's trailing earnings. FONR's current PE ratio of 17.60x is calculated by dividing its stock price of $19.09 by its TTM earnings per share of $1.08. +67.3% elevated vs 5Y avg 10.5x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%8.3x
MedianQ3 · 75%17.0x
Max
At 17.60x, FONR's current P/E is higher than in 100% of its annual fiscal year readings over the past 16 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
FONAR CorporationYou FONR | $118M | 17.60x | — | $1.08 |
 Apyx Medical Corporation APYX | $200M | N/A | — | -$0.27 |
 Artiva Biotherapeutics, Inc. ARTV | $168M | N/A | — | -$3.43 |
 Edap Tms S.a. EDAP | $178M | N/A | — | -$0.78 |
 Hyperfine, Inc. HYPR | $119M | N/A | — | -$0.38 |
 InflaRx N.V. IFRX | $124M | N/A | — | -$0.68 |
 Pulmonx Corporation LUNG | $63M | N/A | — | -$1.33 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | 11.34x | $1.32 | +16.9% | |
2024-06-30 FY2024 | 9.70x | $1.66 | -20.0% | |
2023-06-30 FY2023 | 12.12x | $1.41 | +51.5% | |
2022-06-30 FY2022 | 8.00x | $1.90 | -30.1% | |
2021-06-30 FY2021 | 11.45x | $1.54 | -32.6% | |
2020-06-30 FY2020 | 16.99x | $1.26 | +88.1% | |
2019-06-30 FY2019 | 9.03x | $2.37 | +14.8% | |
2018-06-30 FY2018 | 7.86x | $3.38 | -15.0% | |
2017-06-30 FY2017 | 9.26x | $3.00 | +11.1% | |
2016-06-30 FY2016 | 8.33x | $2.44 | +64.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for FONAR Corporation (FONR) measures how much investors pay for each dollar of the company's trailing earnings. FONR's current PE ratio of 17.60x is calculated by dividing its stock price of $19.09 by its TTM earnings per share of $1.08.
Frequently asked questions
FONR pe ratio · 6 questionsFONR's current PE ratio is 17.60x as of 2026-06-09, based on a stock price of $19.09 and TTM EPS of $1.08. Data sourced from Financial Modeling Prep via FONR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · FONAR Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09